Amedica (AMDA) Misses Q1 Estimates on Top and Bottom Lines

Amedica (NASDAQ: AMDA) reported Q1 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.98 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst